• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Deprescribing Proton Pump Inhibitors.停用质子泵抑制剂
Can J Hosp Pharm. 2018 Sep-Oct;71(5):291-292. Epub 2018 Oct 31.
2
Deprescribing proton pump inhibitors: A study in hospitalized patients in Slovenia.停用质子泵抑制剂：斯洛文尼亚住院患者研究。
Int J Clin Pharmacol Ther. 2023 Jul;61(7):306-314. doi: 10.5414/CP204374.
3
Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study.疗养院居民停用他汀类药物和质子泵抑制剂的实用探索性研究。
Gerontol Geriatr Med. 2021 Oct 24;7:23337214211050807. doi: 10.1177/23337214211050807. eCollection 2021 Jan-Dec.
4
Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients.探讨质子泵抑制剂停药问题：丹麦全科医生和老年患者的观点。
BMC Fam Pract. 2020 Aug 8;21(1):160. doi: 10.1186/s12875-020-01227-5.
5
Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.以患者为中心的减停药物过程以减少质子泵抑制剂不适当使用的可行性。
Ann Pharmacother. 2015 Jan;49(1):29-38. doi: 10.1177/1060028014558290. Epub 2014 Nov 10.
6
Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review.质子泵抑制剂减量患者教育材料的适宜性：重点综述。
Eur J Clin Pharmacol. 2020 Jan;76(1):17-21. doi: 10.1007/s00228-019-02779-x. Epub 2019 Nov 6.
7
Development of Patient Education Material for Proton Pump Inhibitor Deprescribing: A Mixed-Methods Study.质子泵抑制剂减药患者教育材料的开发：一项混合方法研究。
Ann Pharmacother. 2022 Jul;56(7):800-808. doi: 10.1177/10600280211046630. Epub 2021 Sep 23.
8
Deprescribing in a family health team: a study of chronic proton pump inhibitor use.家庭健康团队中的减药：一项关于慢性质子泵抑制剂使用情况的研究。
J Prim Health Care. 2016 Jun;8(2):164-71. doi: 10.1071/HC15946.
9
Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.质子泵抑制剂停用指南对长期护理中药物使用和成本的影响。
J Am Med Dir Assoc. 2016 Jul 1;17(7):673.e1-4. doi: 10.1016/j.jamda.2016.04.020. Epub 2016 Jun 8.
10
Deprescribing proton pump inhibitors.减停质子泵抑制剂。
Aust J Gen Pract. 2022 Nov;51(11):845-848. doi: 10.31128/AJGP-07-22-6497.

引用本文的文献

1
Drug-Induced Cognitive Impairment.药物性认知障碍
Drug Saf. 2025 Apr;48(4):339-361. doi: 10.1007/s40264-024-01506-5. Epub 2024 Dec 24.
2
Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit.不适当的质子泵抑制剂兰索拉唑在长期护理病房住院老年人中的处方。
Ir J Med Sci. 2023 Aug;192(4):1661-1664. doi: 10.1007/s11845-022-03207-3. Epub 2022 Nov 4.
3
De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project.终末期肾病患者停用质子泵抑制剂：一项质量改进项目。
Can J Kidney Health Dis. 2022 Jun 26;9:20543581221106244. doi: 10.1177/20543581221106244. eCollection 2022.
4
Deprescribing Inappropriate Proton Pump Inhibitors in a Family Medicine Residency Practice Office.在家庭医学住院医师培训实践办公室停用不适当的质子泵抑制剂
PRiMER. 2021 Nov 2;5:43. doi: 10.22454/PRiMER.2021.290175. eCollection 2021.
5
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project.以患者为中心的质子泵抑制剂成功撤药方案：DESPIBP 项目。
Eur J Clin Pharmacol. 2021 Dec;77(12):1927-1933. doi: 10.1007/s00228-021-03186-x. Epub 2021 Jul 16.
6
Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic: Quality Improvement Project.在学术性初级保健诊所中停用质子泵抑制剂：质量改进项目。
J Clin Gastroenterol. 2020 Nov/Dec;54(10):864-870. doi: 10.1097/MCG.0000000000001317.

本文引用的文献

1
Evaluation of Prescribing Appropriateness and Initiatives to Improve Prescribing of Proton Pump Inhibitors at Vancouver General Hospital.温哥华总医院质子泵抑制剂处方适宜性评估及改善处方的举措
Can J Hosp Pharm. 2018 Sep-Oct;71(5):308-315. Epub 2018 Oct 31.
2
Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents.量化长期护理居民中停用质子泵抑制剂的适宜性
Can J Hosp Pharm. 2018 Sep-Oct;71(5):302-307. Epub 2018 Oct 31.
3
Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia.质子泵抑制剂的使用有依据吗？对不列颠哥伦比亚省住院护理患者处方情况的评估。
Can J Hosp Pharm. 2018 Sep-Oct;71(5):295-301. Epub 2018 Oct 31.
4
Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.老年人使用质子泵抑制剂的不良反应：证据综述
Ther Adv Drug Saf. 2017 Sep;8(9):273-297. doi: 10.1177/2042098617715381. Epub 2017 Jun 29.
5
Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.停用质子泵抑制剂：循证临床实践指南。
Can Fam Physician. 2017 May;63(5):354-364.
6
What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.老年患者减药的优先事项有哪些？倾听从业者的声音：一种改良的德尔菲法。
PLoS One. 2015 Apr 7;10(4):e0122246. doi: 10.1371/journal.pone.0122246. eCollection 2015.
7
Deprescribing: what is it and what does the evidence tell us?减药：它是什么，证据又告诉了我们什么？
Can J Hosp Pharm. 2013 May;66(3):201-2. doi: 10.4212/cjhp.v66i3.1261.

Deprescribing Proton Pump Inhibitors.

作者信息

Zed Peter J

机构信息

, BSc, BSc(Pharm), ACPR, PharmD, FCSHP, is Professor and Associate Dean, Practice Innovation, Faculty of Pharmaceutical Sciences, and Associate Member, Department of Emergency Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia. He is also an Associate Editor with the Canadian Journal of Hospital Pharmacy.

出版信息

Can J Hosp Pharm. 2018 Sep-Oct;71(5):291-292. Epub 2018 Oct 31.

PMID:30401992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6209504/
Abstract
摘要